Ultrathin bioresorbable polymer sirolimus‐eluting stents in US patients undergoing coronary revascularization: 1‐Year outcomes from the BIOFLOW VII trial

• Published in: Catheterization and cardiovascular interventions Vol. 102; no. 3; pp. 464 - 471
• Main Authors: Kandzari, David E., Garcia‐Garcia, Hector M., Stoler, Robert C., Wang, John, Picone, Mark, Ben‐Dor, Itsik, Garcia, Santiago A.
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.09.2023
• Subjects: Angiography; Clinical trials; Diabetes mellitus; Implants; Myocardial infarction; Rapamycin; Stents; Thrombosis; United States > US; percutaneous coronary intervention; bioresorbable polymer; ultrathin strut drug-eluting stent; myocardial infarction; sirolimus

Ultrathin strut coronary drug-eluting stents (DES) have demonstrated improved safety and efficacy in large contemporary trials. The evaluation of an ultrathin strut DES in a post-market United States (US) patient population was undertaken. The purpose of this post-approval study is to confirm that t...